Position in AVXL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,323,347
+$1,790,009 QoQ
Shares Held
756,792
+405.2% QoQ
Ownership
0.817%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. AVXL ranks #84 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in AVXL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,323,347 | 756,792 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $533,338 | 149,815 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $249,519 | 28,036 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $267,960 | 29,063 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $250,027 | 29,141 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $518,902 | 48,315 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $776,137 | 136,644 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $190,823 | 45,219 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $93,645 | 18,398 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $173,175 | 18,601 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $109,987 | 16,792 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $108,397 | 13,333 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $106,619 | 12,441 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $235,000 | 25,378 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $265,956 | 25,771 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $243,263 | 24,302 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $349,837 | 28,419 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $632,563 | 36,480 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $549,736 | 30,626 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $667,397 | 29,195 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $424,864 | 28,419 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $214,012 | 39,632 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $172,617 | 37,938 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $177,193 | 36,015 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $64,760 | 20,559 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||